Dollar trade may be turning: Barclays
Dollar trade may be turning: Barclays
Source link
Similar Posts
467: High-Achiever Mentality | Trading Motivation
Listen to the audio episode: Get The Complete Price Action Strategy Checklist! High-Achiever Mentality In episode 467 of the Desire To Trade Podcast, you will hear trading motivation from top-tier traders on how to move up to the next level. What mindset do you need? Watch how these traders made their way to success. This…
Most Accurate Reversal MT5 Indicator – ForexMT4Indicators.com
The Most Accurate Reversal MT5 Indicator operates on a simple but effective principle: it monitors both price movement and the 14-period RSI simultaneously, looking for divergences. When GBP/JPY pushes to a new high at 184.50 but the RSI reading comes in lower than the previous peak, that’s bearish divergence. The indicator flags this automatically with…
AUD/USD Price Forecast: Remains bullish despite hovering around 0.7200 | FXStreet
AUD/USD holds to minimal gains of 0.10% late in the North American session, yet poised to finish the week up 0.84%. At the time of writing, the pair trades above 0.7200 as the ‘bullish engulfing’ chart pattern caps the Aussie on the downside. AUD/USD Price Forecast: Technical outlook From a technical perspective, the AUD/USD trades…
Dollar Slides Further as Tariff Worries Resurface! – Orbex Forex Trading Blog
Dollar Slides Further as Tariff Worries Resurface! XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX” width=”0″ style=”display:none;visibility:hidden”> Source link
XAU/USD. Analysis, Forecast, and Current Market Situation
Gold is maintaining a bearish intraday tone today.Oscillators on the daily chart are just beginning to show negative momentum, indicating the potential for further declines in the metal’s price. The XAU/USD pair has repeatedly failed to break above the 100-period Simple Moving Average (SMA) on the 4-hour chart, leading to a drop in price to…
Vincerx Pharma To Merge With Oqory; Cuts Jobs
Vincerx Pharma Inc. (VINC) has announced a binding term sheet for a proposed merger with Oqory Inc., a private clinical-stage company focused on developing antibody-drug conjugates (ADCs) for various oncology treatments. VINC’s stock closed Friday’s regular session at $0.1940, marking an increase of $0.0101, or 5.49%. The stock further surged in after-hours trading, gaining $0.13,…
